VICTORIA GELB: Open Payments
NPI 1366016701 · WEST LAFAYETTE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,271 in 69 payments from 19 companies in 2025. Trend: 2023 $906 · 2024 $1,131 · 2025 $1,271
Food & beverage: $1,252Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 16 | $258 |
| PFIZER INC. | 8 | $156 |
| ABBVIE INC. | 11 | $148 |
| Otsuka America Pharmaceutical, Inc. | 4 | $102 |
| Novo Nordisk Inc | 4 | $101 |
| Astellas Pharma US Inc | 3 | $76 |
| Abbott Laboratories | 3 | $71 |
| Amgen Inc. | 3 | $54 |
| Lilly USA, LLC | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
Products named: AIRSUPRA, REXULTI, NURTEC ODT, Veozah, FREESTYLE LIBRE 3, UBRELVY, QULIPTA, Ozempic.
Industry payments across IN — which companies pay providers there.
